can tirzepatide cause heart problems increased rate Did you know the benefits of tirzepatide go far beyond Mounjaro, Zepbound Lowers Risk of

Tirzepatide (Mounjaro/Zepbound), the dual GLP-1/GIP agonist, has 2-3 years of real-world experience with roughly 5-7 million patients and shows a similar pattern of sustained effectiveness

Recently, new therapies like Keytruda have radically changed the treatment of cancer, while more established therapies, like GLP-1s and SGLT2 inhibitors, have suddenly changed the treatment of diabetes and heart failure, respectively

Ruhoy were talking about the new GLP-1 RA agonists, anti-obesity drugs, that have pretty much been taking the world by storm

This is not a decision to make alone or without full disclosure to your treatment team

This helps monitor your reaction to the dose and presence of any side effects, like nausea or dizziness, that can happen when treatment is first started

Constipation or diarrhea may occur as the medication affects digestive processes